Keith A. Reynolds

The Trump administration reversed course saying that the administration of vaccines has been “too narrowly focused.”

A study of COVID-19 testing in the St. Louis area shows the inequities still present in a critical part of fighting the pandemic.

The open letter to the HHS secretary urges him to be more transparent about the vaccine rollout.

Top reasons cited to refuse the shots include questions of safety and effectiveness.

The new company will seek to advance a more modern information and technology-enabled healthcare platform.

Data from the COVID tracking project on coronavirus cases, test results and more.

Cyber-attacks are up 45 percent worldwide since Nov. 1.

Data from the COVID tracking project on coronavirus cases, test results and more.

The webinar will look at the structural inequities that has led to disproportionate impacts of the virus among racial and ethnic minority groups.

After an official floated the idea of only giving patients a partial dose of Moderna’s vaccine, the FDA stepped in to clarify.

The seven organizations have developed recommendation to transform the way primary care is financed.

Update: Physician organizations are speaking out against the issue.

The drug maker revised its lower estimate for global production by 100 million doses.

The rule tasks hospitals with posting the pricing information online about the items and services they provide.

Almost all of this year’s proposed measures would be collected digitally, freeing physicians from manually retrieving data.

Data from the COVID tracking project on coronavirus cases, test results, and more.

The $900 billion compromise stimulus bill was passed very late Monday evening as part of a $2.3 trillion omnibus spending bill.

Data from the COVID tracking project on coronavirus cases, test results and more

Details are scant on the proposed $900 billion compromise as the midnight deadline approaches.

Data from the COVID tracking project on coronavirus cases, test results and more.

Moderna‘s vaccine showed 94.1 percent efficacy in patients 16 and older.

A regulatory panel has given the vaccine approval leaving only the official EUA approval before distribution.

After a review of phase three applications, the department will release $4.5 billion more than initially anticipated.

A survey has found an increase in the share of the general public willing to receive a COVID-19 vaccine.

The organization supports recommendations for the Pfizer BioNTech vaccine.

The vaccine is expected to be authorized for emergency use later this week.

The changes are intended to remove barriers to coordinated care and reduce regulatory burden.

While there are myriad apps available in digital storefronts hosted by Apple, Google and Amazon, it can be difficult to choose an effective app that also keeps patient health data safe.

The authorization came late Friday night.

The Vaccines and Related Biological Products Advisory Committee approved the vaccine, BNT162b2, paving the way to emergency use authorization.